Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zurzuvae
Pharma
Lilly's Kisunla, Gilead's PrEP drug Yeytuo gain CHMP nods
Europe's CHMP has issued positive opinions on Eli Lilly's Alzheimer's treatment Kisunla and Gilead's breakthrough PrEP drug Yeytuo.
Kevin Dunleavy
Jul 25, 2025 11:03am
Sage lays off entire staff of 338 amid Supernus acquisition
Jun 30, 2025 10:46am
Beleaguered Sage bought for $561M
Jun 16, 2025 11:52am
As new launches take flight, 'a new Biogen' emerges, CEO says
May 1, 2025 11:55am
Biogen places chips behind 4 new drugs as MS competition mounts
Feb 12, 2025 11:35am
Sage rebuffs Biogen's buyout offer, eyes strategic alternatives
Jan 27, 2025 3:03pm
